Plasma fatty acid lipidome is associated with cirrhosis prognosis and graft damage in liver transplantation

American Journal of Clinical Nutrition

Volumn 100, Issue 2, 2014, Pages 600-608

  Corradini, Stefano Ginanni ^a   Zerbinati, Chiara ^a   Maldarelli, Federica ^a   Palmaccio, Giuseppina ^a   Parlati, Lucia ^a   Bottaccioli, Anna Giulia ^a   Molinaro, Antonio ^a   Poli, Edoardo ^a   Boaz, Mona ^c   Serviddio, Gaetano ^d   Mennini, Gianluca ^a   Corsi, Alessandro ^b   Bianco, Paolo ^b   Rossi, Massimo ^a   Iuliano, Luigi ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ARIEL UNIVERSITY   (Israel)

^d UNIVERSITY OF FOGGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DIHOMO GAMMA LINOLENIC ACID; FATTY ACID; HEXACOSANOIC ACID;

ADOLESCENT; ADVERSE EFFECTS; AGED; BLOOD; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRAFT SURVIVAL; HUMAN; LIVER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NECROSIS; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; REPERFUSION INJURY; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; YOUNG ADULT;

8,11,14-EICOSATRIENOIC ACID; ADOLESCENT; AGED; BIOLOGICAL MARKERS; COHORT STUDIES; FATTY ACIDS; FEMALE; GRAFT SURVIVAL; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; NECROSIS; PROGNOSIS; REPERFUSION INJURY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84905405252     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.113.074427     Document Type: Article

References (32)

1. Bistrian BR. Clinical aspects of essential fatty acid metabolism: Jonathan Rhoads Lecture. JPEN J Parenter Enteral Nutr 2003;27:168-75.
2. Wilcox HG, Dunn GD, Schenker S. Plasma long chain fatty acids and esterified lipids in cirrhosis and hepatic encephalopathy. Am J Med Sci 1978;276:293-303.
3. Neuschwander-Tetri BA. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology 2010;52:774-88.
4. El-Badry AM, Graf R, Clavien PA. Omega 3 - omega 6: What is right for the liver? J Hepatol 2007;47:718-25.
5. Fuchs M, Sanyal AJ. Lipotoxicity in NASH. J Hepatol 2012;56:291-3.
6. Shangraw RE, Jahoor F. Lipolysis and lipid oxidation in cirrhosis and after liver transplantation. Am J Physiol Gastrointest Liver Physiol 2000;278:G967-73.
7. Li Z, Berk M, McIntyre TM, Gores GJ, Feldstein AE. The lysosomalmitochondrial axis in free fatty acid-induced hepatic lipotoxicity. Hepatology 2008;47:1495-503.
8. Listenberger LL, Han X, Lewis SE, Cases S, Farese RV, Ory DS, Schaffer JE. Triglyceride accumulation protects against fatty acidinduced lipotoxicity. Proc Natl Acad Sci USA 2003;100:3077-82.
9. Pazirandeh S, Ling P-R, Ollero M, Gordon F, Burns DL, Bistrian BR. Supplementation of arachidonic acid plus docosahexaenoic acid in cirrhotic patients awaiting liver transplantation: a preliminary study. JPEN J Parenter Enteral Nutr 2007;31:511-6.
10. Cabré E, Hernández-Pérez JM, Fluvià L, Pastor C, Corominas A, Gassull MA. Absorption and transport of dietary long-chain fatty acids in cirrhosis: a stable-isotope-tracing study. Am J Clin Nutr 2005;81:692-701.
11. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. Transplantation 1993;55:1265-72.
12. Lepage G, Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 1986;27:114-20.
13. Masood A. A simplified and efficient method for the analysis of fatty acid methyl esters suitable for large clinical studies. J Lipid Res 2005;46:2299-305.
14. Iuliano L, Pacelli A, Ciacciarelli M, Zerbinati C, Fagioli S, Piras F, Orfei MD, Bossu P, Pazzelli F, Serviddio G, et al. Plasma fatty acid lipidomics in amnestic mild cognitive impairment and alzheimer's disease. J Alzheimers Dis 2013;36:545-53.
15. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, Lake J, Howard T, Merion RM, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91-6.
16. Corradini SG, Micheletta F, Natoli S, Iappelli M, Di Angelantonio E, De Marco R, Elisei W, Siciliano M, Rossi M, Berloco P, et al. High preoperative recipient plasma 7beta-hydroxycholesterol is associated with initial poor graft function after liver transplantation. Liver Transpl 2005;11:1494-504.
17. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc Series B Methodol 1995:289-300.
18. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-9.
19. de la Maza MP, Hirsch S, Nieto S, Petermann M, Bunout D. Fatty acid composition of liver total lipids in alcoholic patients with and without liver damage. Alcohol Clin Exp Res 1996;20:1418-22.
20. Cabré E, Periago JL, Mingorance MD, Fernández-Bañares F, Abad A, Esteve M, Gil A, Lachica M, González-Huix F, Gassull MA. Factors related to the plasma fatty acid profile in healthy subjects, with special reference to antioxidant micronutrient status: a multivariate analysis. Am J Clin Nutr 1992;55:831-7.
21. Mayneris-Perxachs J, Guerendiain M, Castellote AI, Estruch R, Covas MI, Fitó M, Salas-Salvadó J, Martínez-González MA, Aros F, Lamuela-Raventós RM, et al. Plasma fatty acid composition, estimated desaturase activities, and their relation with the metabolic syndrome in a population at high risk of cardiovascular disease. Clin Nutr 2014;33:90-7.
22. Tietge UJ, Boker KH, Bahr MJ, Weinberg S, Pichlmayr R, Schmidt HH, Manns MP. Lipid parameters predicting liver function in patients with cirrhosis and after liver transplantation. Hepatogastroenterology 1998;45:2255-60.
23. Jakobsson A, Westerberg R, Jacobsson A. Fatty acid elongases in mammals: their regulation and roles in metabolism. Prog Lipid Res 2006;45:237-49.
24. De Craemer D, Pauwels M, Roels F. Peroxisomes in cirrhosis of the human liver: a cytochemical, ultrastructural and quantitative study. Hepatology 1993;17:404-10.
25. Cui W, Chen SL, Hu K-Q. Quantification and mechanisms of oleic acidinduced steatosis in HepG2 cells. Am J Transl Res 2010;2:95-104.
26. Malhi H, Barreyro FJ, Isomoto H, Bronk SF, Gores GJ. Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity. Gut 2007;56:1124-31.
27. Zulyniak MA, Ralston JC, Tucker AJ, MacKay KA, Hillyer LM, McNicholas PD, Graham TE, Robinson LE, Duncan AM, Ma DW, et al. Vaccenic acid in serum triglycerides is associated with markers of insulin resistance in men. Appl Physiol Nutr Metab 2012;37:1003-7.
28. Øie E, Ueland T, Dahl CP, Bohov P, Berge C, Yndestad A, Gullestad L, Aukrust P, Berge RK. Fatty acid composition in chronic heart failure: low circulating levels of eicosatetraenoic acid and high levels of vaccenic acid are associated with disease severity and mortality. J Intern Med 2011;270:263-72.
29. Wang X, Lin H, Gu Y. Multiple roles of dihomo-γ-linolenic acid against proliferation diseases. Lipids Health Dis 2012;11:25.
30. Harvey KA, Walker CL, Xu Z, Whitley P, Siddiqui RA. Trans fatty acids: induction of a pro-inflammatory phenotype in endothelial cells. Lipids 2012;47:647-57.
31. Qiu B, Hu J-N, Liu R, Fan Y-W, Li J, Li Y, Deng ZY. Caspase pathway of elaidic acid (9t-C18:1)-induced apoptosis in human umbilical vein endothelial cells. Cell Biol Int 2012;36:255-60.
32. Johnson TM, Overgard EB, Cohen AE, Di Baise JK. Nutrition assessment and management in advanced liver disease. Nutr Clin Pract 2013;28:15-29.